Asset Publisher
National Oncology Center Organizes 13th Muscat International Oncology Conference
National Oncology Center Organizes 13th Muscat International Oncology Conference
4/3/2023The Ministry of Health (MOH), represented by the National Oncology Center of the Royal Hospital, organized the 13th Muscat International Oncology Conference at Crowne Plaza Hotel.
H.E. Dr. Fatima bint Mohammad Al-Ajami, MOH Undersecretary for Administrative, Financial, and Planning Affairs, inaugurated the Conference with the presence of Dr. Sami Al-Farsi, Director General of the Royal Hospital, Dr. Suad Al-Kharousi, Director of the National Oncology Center, along with several officials and medical staff.
Dr. Suad Al-Kharousi confirmed that this Conference had been held annually since 2009 and continued to be held during the Covid-19 pandemic via visual communication.
Al-Kharousi added that the Conference is an annual scientific meeting for oncologists to keep pace with the latest information on oncology. She indicated that a continuing education forum would be opened during this Conference to exchange knowledge.
The Conference targeted medical and paramedical categories from health institutions and centers specialized in cancer from various governorates of the Sultanate of Oman.
A number of local and international experts concerned with medical specialties in cancer attended the Conference.
The two-day Conference presented and discussed scientific and research working papers on various topics related to the diagnosis and treatment of cancer, namely colon cancer, immunotherapy for cancer, challenges in management of bone tumors in adolescents, diagnosis and methods of treatment of brain cancers among children, palliative medicine and its role in treating Cancer, new standards in the treatment of cancers of the urinary bladder, lung cancer, the incidence of cancer in the Sultanate of Oman, breast cancer, gynecological tumors, diseases of the urinary system, methods of diagnosing accurate genes, liver tumors and modern treatment methods, head and neck cancers.